N/A N=23 Taping to Control Edema in Patients With Forearm Plaster for Wrist Fracture.
Edema Arm · Fracture; Wrist
Primary: Thumb Circumference — -0.2; 0 cm
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=13 Effect of Virtual Reality-based Training on Balance and Walking in Youth With Autism Spectrum Disorder
Autism Spectrum Disorder
Primary: Change in the Center of Pressure Movement (Postural Sway Velocity) — 0.93; 0.50; 1; 0.8 cm/sec — p=< 0.05
N/A N=30 The Psychosocial Outcomes in Caregivers of Children With Food Allergy
Food Allergy in Children · Caregiver Burnout · Psychosocial Problem
Primary: Fatigue as Assessed by Patient-Reported Outcomes Measurement Information System Fatigue Short Form: PROMIS Short Form 6a — 50.6; 53 score on a scale
N/A N=269 Intervention Trial to Decrease Cardiovascular Risk in Persons With Serious Mental Illness
Cardiovascular Risk Factors · Serious Mental Illness
Primary: Global Framingham Risk Score — 11.5; 12.7; 9.9; 12.3 score on a scale
N/A N=24 A Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
Central Centrifugal Cicatricial Alopecia
Primary: Shape of the Hairline Documented With Photographs — 8; 12; 2 Participants
Phase 3 N=465 Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery
General Anesthesia
Primary: Success Rate of General Anesthesia Induction — 298; 143 Participants
N/A N=708 A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users.
Migraine
Primary: Number of Participants Classified as Per Responses for Satisfaction of Pain Intensity — 539; 625; 130; 178 Participants
N/A N=392 Individualizing Incentives for Alcohol in the Severely Mentally Ill
Schizophrenia · Bipolar Disorder · Major Depressive Disorder
Primary: Alcohol Use Assessed by Ethyl Glucuronide (EtG) Detection in Urine — 0.66; 0.65; 0.61 proportion uEtG negative
N/A N=145 Cognitive Rehabilitation Therapy for Mild Cognitive Impairment
Mild Cognitive Impairment
Primary: Change in Objective Cognitive Performance Composite z Score — .24; .14 Z score
Phase 3 N=34 A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788
Idiopathic Thrombocytopenic Purpura
Primary: Achievement Rate of Stable Platelet Response — 36.4; 0.0 Percentage of participants — p=0.030
Phase 2 N=59 LIPIDS-P Trial Phase I/II Trial
Sepsis, Severe · Septic Shock
Primary: Phase II - Primary Outcome - Change in Total Cholesterol (48 Hours - Enrollment) — 9; -10; 4; 2 mg/dL
N/A N=88 HLA-Identical Sibling Renal Transplant Tolerance
Immunosuppression · Kidney Transplantation · Graft Rejection
Primary: The Ability to Withdraw Immunosuppression as Above 24 Months Post-transplant — 6 Participants
N/A N=600 Noom Health for Weight Management
Weight Loss · Obesity
Primary: Change in Weight From Baseline — 210.1; 211.7; 199.4; 204.6 lbs
N/A N=155 Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk
Diabetes Mellitus
Primary: Change in Global Cognition Score — -0.012; 0.021; 0.18; 0.32 Composite z-score
Phase 3 N=359 Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma
Asthma
Primary: Change From Baseline in Trough Forced Expiratory Volume in 1 Second (FEV1) at Week 12 (100ug FF) — 0.078; 0.136 Liters